Epidermal growth factor receptor inhibitors selectively inhibit the expressions of human β-defensins induced by Staphylococcus epidermidis

Journal of Dermatological Science

Volumn 75, Issue 2, 2014, Pages 94-99

  Park, Kio ^a,b   Ommori, Rie ^b   Imoto, Kyoko ^b   Asada, Hideo ^b  

^a Department of Pediatrics   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Erlotinib; Gefitinib; Human defensins

Indexed keywords

BETA DEFENSIN; BETA DEFENSIN 1; BETA DEFENSIN 2; BETA DEFENSIN 3; ERLOTINIB; GEFITINIB; BETA-DEFENSIN 3, HUMAN; DEFB4A PROTEIN, HUMAN; EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN KINASE INHIBITOR; QUINAZOLINE DERIVATIVE;

ARTICLE; BACTERIAL COLONIZATION; CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; INNATE IMMUNITY; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOGENICITY; SIGNAL TRANSDUCTION; TIME; TOXICITY;

BETA-DEFENSINS; CELLS, CULTURED; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; KERATINOCYTES; PROTEIN KINASE INHIBITORS; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TIME FACTORS;

EID: 84902768354     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2014.04.011     Document Type: Article

References (12)

1. Lacouture M.E. Mechanisms of cutaneous toxicities to EGFR inhibitors. Nat Rev Cancer 2006, 6:803-812.
2. Tuzun Y., Antonov M., Dolar N., Wolf R. Keratinocyte cytokine and chemokine receptors. Dermatol Clin 2007, 25:467-476.
3. Schroder J.M., Harder J. Antimicrobial skin peptides and proteins. Cell Mol Life Sci 2006, 63:469-486.
4. Brogden K.A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nat Rev Microbiol 2005, 3:238-250.
5. White T.J., Bruns T., Lee S., Taylor J. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. PCR protocols: a guide to methods and applications 1990, 315-322. Academic Press, Inc, New York. M.A. Innis, D.H. Gelfand, SninskyJJ, T.J. White (Eds.).
6. Cogen A.L., Nizet V., Gallo R.L. Skin microbiota: a source of disease or defence?. Br J Dermatol 2008, 158:442-455.
7. Harder J., Meyer-Hoffert U., Teran L.M., Schwichtenberg L., Bartels J., Maune S., et al. Mucoid Oseudomonas aeruginosa, TNF-alpha, and IL-1beta, but not IL-6, induce human beta-defensin-2 in respiratory epithelia. Am J Respir Cell Mol Biol 2000, 22:714-721.
8. Lai Y., Cogen A.L., Radek K.A., Park H.J., MacLeod D.T., Leichtle A., et al. Activation of TLR2 by a small molecule produced by Staphylococcus epidermidis increases antimicrobial defense against bacterial skin infections. J Invest Dermatol 2010, 130:2211-2221.
9. Ommori R., Ouji N., Mizuno F., Kita E., Ikeda Y., Asada H. Selective induction of antimicrobial peptides from keratinocytes by staphylococcal bacteria. Microb Pathog 2013, 56:35-39.
10. Wanke I., Steffen H., Christ C., Krismer B., Gotz F., Peschel A., et al. Skin commnesals amplify the innate immune response to pathogens by activation of distinct signaling pathways. J Invest Dermatol 2011, 131:382-390.
11. Liu K., Anderson G.P., Bozinovski S. DNA vector augments inflammation in epithelial cells via EGFR-dependent regulation of TLR4 and TLR2. Am J Respir Cell Mol Biol 2008, 39:305-311.
12. Midorikawa K., Ouhara K., Komatsuzawa H., Kawai T., Yamada S., Fujiwara T., et al. Staphylococcus aureus susceptibility to innate antimicrobial peptides, β-defensins and CAP18, expressed by human keratinocytes. Infect Immun 2003, 71:3730-3739.